Behavioral Effects of d-Amphetamine in Humans: Influence of Subclinical Levels of Inattention and Hyperactivity

被引:3
|
作者
Sevak, Rajkumar J.
Stoops, William W.
Rush, Craig R. [1 ,2 ,3 ]
机构
[1] Univ Kentucky, Albert B Chandler Med Ctr, Dept Behav Sci, Coll Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Albert B Chandler Med Ctr, Dept Psychiat, Lexington, KY 40536 USA
[3] Univ Kentucky, Dept Psychol, Lexington, KY 40536 USA
关键词
substance abuse; attention-deficit hyperactivity disorder; behavior; d-amphetamine; hyperactivity; inattention; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DISCRIMINATIVE-STIMULUS; SUBSTANCE USE; METHYLPHENIDATE; TRIAZOLAM; ABUSE; METHAMPHETAMINE; DEPENDENCE; NICOTINE; SYMPTOMS;
D O I
10.3109/00952990.2010.494213
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: Several studies suggest a link between stimulant abuse and attention-deficit hyperactivity disorder (ADHD) symptoms (e. g., inattention and hyperactivity). To further assess the nature of this relationship, the present study examined the association between subclinical symptoms of inattention and hyperactivity and the behavioral effects of d-amphetamine. Methods: Participants were classified into a High-(n = 8) or Low-Score (n = 9) group based on their responses on a rating scale that assessed inattention and hyperactivity symptoms. Results: The participants did not differ across the High-Score and Low-Score groups in their ability to discriminate d-amphetamine. The participants in the High-Score group were significantly more sensitive to the positive participant-rated effects of d-amphetamine (e. g., Good Effects, Like Drug), but less sensitive to drug-induced increases in blood pressure and heart rate. Conclusion: The selective increase in positive subjective effects of d-amphetamine suggests that individuals with subclinical inattention and hyperactivity symptoms may have increased vulnerability to stimulant abuse.
引用
收藏
页码:220 / 227
页数:8
相关论文
共 50 条
  • [41] Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans
    K. E. Hutchison
    Robert Swift
    Psychopharmacology, 1999, 143 : 394 - 400
  • [42] Effects of d-amphetamine on behavioral control in stimulant abusers:: the role of prepotent response tendencies
    Fillmore, MT
    Rush, CR
    Marczinski, CA
    DRUG AND ALCOHOL DEPENDENCE, 2003, 71 (02) : 143 - 152
  • [43] Influence of calcium channel antagonists on nonsomatic signs of nicotine and D-amphetamine withdrawal in mice
    Biala, Grazyna
    Polak, Piotr
    Michalak, Agnieszka
    Kruk-Slomka, Marta
    Budzynska, Barbara
    PHARMACOLOGICAL REPORTS, 2014, 66 (02) : 212 - 222
  • [44] Hyperactivity following postnatal NMDA antagonist treatment: Reversal by D-amphetamine
    Anders Fredriksson
    Trevor Archer
    Neurotoxicity Research, 2003, 5 : 549 - 564
  • [45] Preference reversals and effects of D-amphetamine on delay discounting in rats
    Krebs, Christopher A.
    Anderson, Karen G.
    BEHAVIOURAL PHARMACOLOGY, 2012, 23 (03): : 228 - 240
  • [46] DIFFERENTIAL EFFECTS OF METHYLPHENIDATE AND D-AMPHETAMINE ON STEREOTYPED BEHAVIOR IN THE RAT
    PECHNICK, R
    JANOWSKY, DS
    JUDD, L
    PSYCHOPHARMACOLOGY, 1979, 65 (03) : 311 - 315
  • [47] Stereotyped behavior: Effects of d-amphetamine and methylphenidate in the young rat
    Roffman, JL
    Raskin, LA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 58 (04) : 1095 - 1102
  • [48] Modulation of the stimulus effects of morphine by d-amphetamine
    Gaiardi, M
    Bartoletti, M
    Gubellini, C
    Bacchi, A
    Babbini, M
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 59 (01) : 249 - 253
  • [49] One-trial behavioral sensitization in preweanling rats: differential effects of cocaine, methamphetamine, methylphenidate, and d-amphetamine
    Sanders A. McDougall
    Olga O. Kozanian
    Venuz Y. Greenfield
    Leslie R. Horn
    Arnold Gutierrez
    Alena Mohd-Yusof
    Kevin A. Castellanos
    Psychopharmacology, 2011, 217 : 559 - 571
  • [50] SELECTIVE TOLERANCE TO DISCRIMINATIVE STIMULUS EFFECTS OF MORPHINE OR D-AMPHETAMINE
    YOUNG, AM
    WALTON, MA
    CARTER, TL
    BEHAVIOURAL PHARMACOLOGY, 1992, 3 (03): : 201 - 209